Alnylam Pharmaceuticals, Inc.
Close on Nov 20, 2026Market cap $19.26BP/E 7.5Yield –
Alnylam Pharmaceuticals Net Cash Provided by Financing Activities
Net Cash Provided by Financing Activities ($M)
Alnylam Pharmaceuticals Net Cash Provided by Financing Activities: $18.4M in Q3 2026, down 104.4% from a year earlier.
Where the Q3 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Alnylam Pharmaceuticals Net Cash Provided by Financing Activities ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Alnylam Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/alny/kpis/db-financing-cf
See every metric in the Alnylam Pharmaceuticals KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?